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Chemotherapy resistance poses severe limitations on the efﬁcacy of anti-cancer medications. Recently, the notion of using
novel combinations of ‘old’ drugs for new indications has garnered signiﬁcant interest. The potential of using phenothiazines as
chemosensitizers has been suggested earlier but so far our understanding of their molecular targets remains scant. The current
study was designed to better deﬁne phenothiazine-sensitive cellular processes in relation to chemosensitivity. We found that
phenothiazines shared the ability to delay cH2AX resolution in DNA-damaged human lung cancer cells. Accordingly, cells co-
treated with chemotherapy and phenothiazines underwent protracted cell-cycle arrest followed by checkpoint escape that led to
abnormal mitoses, secondary arrest and/or a form of apoptosis associated with increased endogenous oxidative stress and
intense vacuolation. We provide evidence implicating lysosomal dysfunction as a key component of cell death in phenothiazine
co-treated cells, which also exhibited more typical hallmarks of apoptosis including the activation of both caspase-dependent
and -independent pathways. Finally, we demonstrated that vacuolation in phenothiazine co-treated cells could be reduced by
ROS scavengers or the vacuolar ATPase inhibitor baﬁlomycin, leading to increased cell viability. Our data highlight the potential
beneﬁt of using phenothiazines as chemosensitizers in tumors that acquire molecular alterations rendering them insensitive to
caspase-mediated apoptosis.
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Genomic DNA constitutes a major target of many commonly
used chemotherapeutic agents, including bleomycin and
cisplatin. These drugs generate a complex array of DNA
lesions some of which, such as DNA double-strand breaks
(DSB) and interstrand crosslinks (ICLs), are highly lethal to
proliferating cells by blocking DNA replication and transcrip-
tion. To combat these toxic damages, mammalian cells are
armed with several partially overlapping DNA repair path-
ways.
1 DNA DSBs trigger the prompt phosphorylation of
serine-139 on histone H2AX (gH2AX), which serves as
platforms to concentrate DNA repair factors locally at the
sites of damage and to activate checkpoint proteins that
enforce cell-cycle arrest.
2,3 In addition, non-DSB lesions such
as ICLs also provoke gH2AX, possibly because ICLs can be
converted into DSBs either by enzymatic activities during
DNA repair
4 or through collapse of the replication fork in S
phase.
5 Dephosphorylation of gH2AX is thought to take place
concurrent to or after DNA repair and is required for efﬁcient
checkpoint recovery.
6 As checkpoint arrest is intimately
coupled to DNA repair, premature resumption of cell
division in the face of unrepaired DNA damage may cause
chromosome separation defects resulting in mitotic
catastrophe and cell death.
7 Indeed, the inability to resolve
gH2AXissigniﬁcantlycorrelatedwithdecreasedcellsurvival.
8
Thus, modulation of gH2AX clearance by inhibition of DNA
repair or through other means has the potential to enhance
tumor killing by DNA-damaging drugs.
DNA damage induces several forms of cell death, including
apoptosis, necrosis and autophagic cell death.
9 Which of
these death modes are induced in a given model system is
dependent on cell-intrinsic properties, as well as the strength
and duration of the death-inducing stimulus. Moreover, cell
death with mixed features is often observed and multiple
modes of cell death may also be simultaneously induced by a
single drug under certain conditions. In general, DNA
damage-induced apoptosis requires the activation of cas-
pases, initiated mainly through the permeabilization of
mitochondria by pro-apoptotic Bcl-2 family members Bax
andBak,
10andtoalesserextentthroughmembrane-proximal
signaling from death receptors.
10 In addition, lysosomal
dysfunction and persistent autophagy have been implicated
in apoptosis upstream of mitochondrial permeabilization.
11,12
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www.nature.com/cddisIncreased generation of reactive oxygen species (ROS) is
frequently observed in cells exposed to DNA-damaging
agents
13 and depending on the particular model system,
ROS signaling has been shown to induce apoptosis,
autophagy, necrosis or premature senescence.
14 The intri-
cateinterplaybetweenvariousstress-responsepathwaysand
their relation to cell death has not been clearly deﬁned.
Phenothiazines are a class of compounds endowed with
dopamine receptor antagonistic activities in the central
nervous system (CNS), and are commonly used as part of
anti-psychotic medication.
15 These compounds are also
cytostatic and/or cytotoxic in a variety of non-CNS cells.
16
Interestingly, phenothiazines such as triﬂuoperazine (TFP)
and chlorpromazine (CPZ) also possess chemosensitizing
properties, although the mechanism behind this remains to be
clariﬁed. Our previous work implicated phenothiazines as
candidate DNA repair inhibitors.
17 In the current study, we
found a novel link between impairment of gH2AX clearance
and enhancement of chemosensitivity by phenothiazines. We
show that persistence of chemotherapy-induced gH2AX in
phenothiazine co-treated lung cancer cells resulted in
prolonged cell-cycle arrest followed by checkpoint escape,
abnormal mitosis and subsequent induction of secondary
arrest and/or cell death. Chemical inhibitor studies indicated
ROS and the lysosomal compartment as relevant mediators
of phenothiazine-induced chemosensitization, while cas-
pases were important but not indispensable for cell death in
this setting. Our data highlight the potential beneﬁt of using
phenothiazines as chemosensitizers in tumors that acquire
molecular alterations rendering them insensitive to caspase-
mediated apoptosis.
Results
Phenothiazines potentiate DNA damage-induced killing
of human lung cancer cells. The clonogenic capacity of
human non-small cell lung carcinoma (NSCLC) U1810 and
H23 cells following DNA-damaging treatment was determined
by colony formation assay in the absence and presence of
10mM TFP (Figure 1a). TFP signiﬁcantly augmented the
cytotoxicity of bleomycin in U1810 cells (Figure 1b).
Application of the Bliss additivism model indicated supra-
additive combination effects across the entire dose range of
bleomycin (Figure 1c). At equimolar concentrations, the
efﬁcacy of TFP as bleomycin sensitizer was superior to that
of the DNA repair inhibitor NU7026 (Figure 1b). TFP also
markedly enhanced cisplatin cytotoxicity in U1810 cells
(Figure 1d). Moreover, TFP sensitized H23 cells to
bleomycin and cisplatin (Supplementary Figure 1a). In
addition to TFP, two other phenothiazines ﬂuphenazine
(FPZ) and triﬂupromazine (TFPZ) also sensitized U1810
cells to cisplatin (Supplementary Figure S1b). These data
conﬁrm phenothiazines as effective sensitizers of DNA-
damaging chemotherapy.
Phenothiazines impair the resolution of chemotherapy-
induced cH2AX. Phosphorylated H2AX (gH2AX) is a useful
surrogate marker for the detection of DNA DSBs
18 as well as
certain types of non-DSB lesions.
5 Exposure of U1810 and
H23 cells to bleomycin (7.5 and 5mg/ml, 1h, respectively)
resulted in immediate and maximal induction of gH2AX
(Figure 2a, t¼0). The removal of bleomycin-induced gH2AX
appeared to be biphasic with a fast phase within the ﬁrst 4h
post-treatment and a slow phase thereafter. Importantly, TFP
signiﬁcantly impeded the resolution of bleomycin-induced
gH2AX during the fast phase in both U1810 and H23 cells
(Figures 2a). Impairment of gH2AX resolution by TFP was
also evident in U1810 cells exposed to a pharmacologically
relevant concentration (2.5mg/ml) of bleomycin (Figure 2b).
In addition, TFPZ delayed gH2AX resolution in bleomycin-
treated U1810 cells (Figure 2c). Unlike bleomycin, cisplatin
triggered a gradual accrual of gH2AX in a subset of U1810
cells that peaked at 6h post-treatment and declined
thereafter (Figure 2d). After 12 and 24h, TFP-co-treated
U1810 cells harbored signiﬁcantly higher levels of gH2AX,
indicating that TFP also delayed the resolution of cisplatin-
induced gH2AX (Figure 2d). The DNA repair inhibitor
NU7026 behaved differently from TFP; NU7026 reduced
the magnitude of gH2AX induction and prevented its removal
in bleomycin-treated U1810 and H23 cells (Figure 2a), but
did not affect either the induction or removal of gH2AX in
cisplatin-treated U1810 cells (Figure 2d). These data
demonstrated that phenothiazines share the ability to
perturb gH2AX dynamics.
Phenothiazines delay the recovery of cells from chemo-
therapy-induced cell-cycle arrest. Phosphorylation and
dephosphorylation of H2AX have been implicated in the
activation and de-activation of DNA damage-inducible cell-
cycle checkpoints, respectively.
2,6 We therefore set out to
examine if impairment of gH2AX resolution by TFP perturbs
checkpoint arrest of U1810 cells exposed to bleomycin or
cisplatin (Figure 3 and Supplementary Figure 2). Bleomycin
treatment caused progressive accumulation of cells in G2-M,
with a peak at about 12h post-treatment (Figure 3a). In the
absence of TFP, recovery from bleomycin-induced G2-M
arrest occurred between 6 and 12h post-treatment, as shown
by increases in the percentage of cells in G1. On the contrary,
only a minority of TFP-co-treated cells progressed from G2-M
to G1 after 18h, suggesting that TFP co-treatment largely
prevented the inactivation of bleomycin-induced G2-M
checkpoint (Figure 3a). Importantly, TFP also retarded the
recovery of U1810 cells from cisplatin-induced S phase
checkpoint (Figure 3b). In the absence of TFP, most S
phase cells recovered between 18 and 24h post-treatment, as
indicated by their progression into G2-M and then G1.B y
contrast, signiﬁcant progression of TFP-co-treated cells was
ﬁrst detected between 24 and 36h (Figure 3b). Thus, delay of
gH2AX resolution by TFP impaired the recovery of U1810 cells
from two molecularly distinct cell-cycle checkpoints triggered
by different DNA lesions that is DNA DSBs versus ICLs.
Phenothiazines allow checkpoint escape leading to
mitotic defects, secondary cell-cycle arrest and
increased apoptosis. To further analyze the impact of
TFP on checkpoint recovery after DNA damage, U1810 cells
were pulse-labeled with CFSE before drug treatment and
chased for up to 96h. Mock-treated cells divided
continuously, as indicated by the progressive dissipation of
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Cell Death and DiseaseCFSE ﬂuorescence (Figure 4a). By contrast, bleomycin-
treated cells retained higher CFSE ﬂuorescence initially after
24h but the differences became insigniﬁcant over time
(Figure 4a). This is consistent with a transient checkpoint-
mediated cell-cycle arrest followed by recovery of proliferative
capacity. In agreement with the slower resolution of gH2AX,
TFP-co-treated cells initially exhibited even higher CFSE
ﬂuorescence than bleomycin-treated cells, indicating a more
prolonged checkpoint response during the ﬁrst 24h post-
treatment (Figure 4a). Importantly, although the majority of
TFP-co-treated U1810 cells subsequently overcame the initial
checkpoint arrest, the percentage of TFP-co-treated cells
displaying hallmarks of abnormal mitosis increased signiﬁ-
cantly after 48h (Figure 4b). A fraction of TFP-co-treated
U1810 cells appeared to undergo secondary arrest 72h post-
treatment (Figure 4a, right panel). The emergence of this
fraction, which was characterized by high CFSE ﬂuorescence,
was also evident when U1810 cells were co-treated with TFPZ
(Figure 4a). Apoptotic DNA fragmentation was also abundant in
TFP-co-treated cells as judged by nuclear morphology
(Figure 4c) and hypo-diploid (subG1) DNA content (data not
shown). Furthermore, the above data clearly showed that
abnormal mitosis preceded apoptosis. Conceivably, the escape
of TFP-co-treated cells from DNA damage-induced checkpoints
before complete resolution of gH2AX resulted in mitotic
chromosomal separation defects that triggered apoptosis.
Phenothiazines augment the proteolytic cleavage and
activation of multiple caspases after DNA-damaging
treatment. Caspases are key mediators of apoptosis in
response to a wide range of harmful insults, including DNA
damage.
19 In agreement with its ability to enhance apoptosis
based on morphological criteria, TFP also augmented
caspase-3 activation in U1810 cells exposed to bleomycin
or cisplatin (Figures 5a and b). The ability of TFP to augment
caspase-3 activation was also observed in bleomycin-treated
H23 cells and was shared by FPZ and CPZ (data not shown).
Nuclear activity of caspase-3 was conﬁrmed by the cleavage
of its substrate PARP (Figure 5c). Notably, active caspase-3
was detected predominantly in U1810 cells with 4n DNA
content (Figure 5a, right panel), suggesting that TFP may
enhance apoptosis as a consequence of defective mitosis.
Activation of caspase-3 can be mediated by multiple initiator
caspases, including caspases-2, -8 and -9.
19 TFP signiﬁ-
cantly augmented the proteolytic cleavage of caspase-8
(Figure 5d and Supplementary Figure S3c) and caspase-9
(Figure 5e) in U1810 cells after DNA damage. The markedly
increased level of catalytically active caspase-9 in TFP-co-
treated U1810 cells (Figure 5f) was associated with
conformational activation of Bak and Bax (Supplementary
Figures S3a) and mitochondrial depolarization (Supplemen-
tary Figure S3b). Thus, TFP potentiated DNA damage-
induced apoptosis by enhancing the activation of both the
intrinsic and the extrinsic pathways.
Phenothiazine-mediated chemosensitization involves
lysosomal dysfunction. Vacuolation is a phenomenon
frequently observed in cells exposed to stressful stimuli,
including chemotherapeutic drugs.
20 Bleomycin triggered
vacuolation in U1810 cells that was visible by light
Figure1 TFPpotentiatesDNAdamage-inducedkillingofhumanlungcancercells.ClonogeniccapacitywasdeterminedforU1810cellsexposedtoDNA-damagingdrugs
alone or in combination with TFP or NU7026 (both 10mM). (a) Outline of drug co-treatment schemes: pre-treatment with 24h post-incubation. For the sake of simplicity, only
TFP co-treatment was shown, although the same strategy was also employed for other chemosensitizers. (b) TFP co-treatment markedly reduced the clonogenic capacity of
cellsexposed to bleomycin.(c) Comparison betweenthe theoreticaldose-responsecurve assumingadditivity betweenbleomycinand TFP (add), as calculatedfrom the Bliss
additivismmodel,withtheobservedexperimentaldata(obs)indicatedthatthecombinatorialeffectwassupra-additive.(d)TFPsigniﬁcantlyreducedtheclonogeniccapacityof
cells exposed to cisplatin. Mean and S.D. were compiled from at least three independent experiments performed in duplicates (*Po0.05, TFP co-treatment versus single-
agent bleo/cis treatment)
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Cell Death and Diseasemicroscopy (Figure 6a) and manifested as time-dependent
increases in side scattering during ﬂow cytometric analysis
(Figure 6b). This suggested that vacuolation constitutes a
part of the cellular stress response to bleomycin in these
cells. Strikingly, TFP-co-treated U1810 cells became
intensely vacuolated over time (Figures 6a and b). Similar
observations were also obtained for TFP-co-treated H23,
H125 and U1752 cells (all NSCLC), and the ability of TFP to
Figure 2 Phenothiazines delay gH2AX resolution in human lung cancer cells. Cells were exposed to DNA-damaging agents alone or in combination with TFP or NU7026
(both 10mM). (a) TFP signiﬁcantly delayed the resolution of gH2AX in U1810 and H23 cells exposed to 7.5mg/ml bleomycin (top left) and 5mg/ml bleomycin (top right),
respectively. Phosphorylation of H2AX (Ser139) was quantiﬁed by ﬂow cytometry using Alexa Fluor 488-conjugated antibodies. The histograms below highlight differences in
cellular Alexa Fluor 488-associated ﬂuorescence at 1h post-bleomycin treatment: shaded, bleo; unshaded, bleoþTFP. For bleomycin-treated cells, the kinetics of gH2AX
resolutionisindicatedbyfoldchangesinthegeometricmeanofAlexaFluor488-associatedﬂuorescence.Anarbitraryvalueof1isassignedtosamplescollectedimmediately
afterbleomycintreatmentintheabsenceofTFP(t¼0h).(b)TFPretardedtheresolutionofgH2AXinU1810cellsexposedto2.5mg/mlbleomycin.PhosphorylatedH2AXwas
detected by immunoblotting. (c) TFPZ impaired the resolution of gH2AX in U1810 cells 1h after exposure to 15mg/ml bleomycin. (d) TFP impeded the resolutionof gH2AX in
U1810cellsexposedto50mMcisplatin.AscisplatininducedgH2AXonlyinasubsetofcells,thekineticsofgH2AXresolutionincisplatin-treatedcellsisdeﬁnedbychangesin
the percentage of cells exhibiting high Alexa Fluor 488-associated ﬂuorescence (gH2AX
High (%)). For (a and d), mean and S.D. were compiled from three independent
experiments performed in duplicates (*Po0.05, TFP co-treatment versus single-agent bleo/cis treatment). For (b and c), one representative experiment is shown (n¼2).
þve, positive control (20mg/ml bleomycin, 1h)
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CPZ and FPZ (data not shown). A fraction of TFP-co-treated
U1810 cells underwent lysosomal membrane permeabili-
zation (LMP), as shown by decreased cellular retention of the
acidophilic dye acridine orange (AO) (Figure 6c). On the
whole population level, however, TFP-co-treated U1810 cells
showed increased retention of AO over time (Figure 6d),
suggesting that early LMP may lead to compensatory
expansion of the cellular acidic compartment. We found an
excellent correlation between AO retention and vacuolation
(Figure 6e). In addition, TFP-co-treated U1810 cells stained
more intensely with the lysosomotropic dye LysoTracker
Green (Figure 6f), indicating that increased retention of AO by
these cells may be due speciﬁcally to the expansion of
lysosomal compartment causing vacuolation. Importantly, the
vacuolar ATPase inhibitor baﬁlomycin A1 reduced the ability of
TFP to enhance AO retention and caspase-3 activation in
bleomycin-treated U1810 cells (Figures 6g and h). Similarly,
baﬁlomycin A1 abrogated the potentiation of bleomycin-induced
caspase-3 activation by CPZ, FPZ or TFPZ (data not shown).
Taken together, these data suggested that phenothiazine-
mediated chemosensitization involves lysosomal dysfunction
upstream of caspase-3 activation.
Phenothiazine-mediated chemosensitization is associated
with increased production of endogenous reactive oxygen
species (ROS). Many classes of DNA-damaging agents
are known to induce oxidative stress,
13,21,22 which is a major
cause for dysfunction of cellular organelles and cell death.
14,23
Exposure of U1810 cells to bleomycin, cisplatin or TFP
alone resulted in moderate increases of intracellular ROS
(Figures 7a and b). Strikingly, TFP synergistically augmented
cellular ROS production following treatment with bleomycin or
cisplatin (Figures 7a and b). Interestingly, this TFP-mediated
rise of intracellular ROS occurred much faster in bleomycin-
treated cells than in cisplatin-treated cells, which is in
agreement with the faster kinetics of apoptosis induction by
bleomycin compared with cisplatin (Figure 4c). Regardless of
the DNA-damaging agent, the onset of oxidative stress in TFP-
co-treated U1810 cells (o24h, Figures 7a and b) clearly
preceded the activation of caspases (48h, Figure 5).
Importantly, the ROS scavenger N-acetylcysteine (NAC)
mitigated oxidative stress and partially rescued the short-term
viability as well as the long-term clonogenic capacity of TFP-co-
treated U1810 cells (Figures 7c and d), suggesting that
exacerbated oxidative stress contributes to the increased
cytotoxicity of TFP co-treatment.
Figure 3 TFP delays the recovery of human lung cancer cells from DNA damage-induced checkpoints. U1810 cells were exposed to DNA-damaging drugs (2.5mg/ml
bleomycin,20mMcisplatin)aloneorincombinationwithTFP(10mM).Atindicatedtimepoints,cell-cycledistributionwasdeterminedbyDNAcontentanalysis.Thedistribution
of mock-treated cells and cells treated with TFP alone are omitted for the sake of simplicity, but can found in Supplementary Figure S2. (a) TFP signiﬁcantly delayed the
recoveryofcellsfrombleomycin-inducedG2-Mcheckpointarrest.(b)TFPsigniﬁcantlydelayedtherecoveryofcellsfromcisplatin-inducedintra-Scheckpointarrest.Meanand
S.D. were compiled from at least three independent experiments performed in duplicates (*Po0.05, TFP co-treatment versus single-agent bleo/cis treatment)
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Phenothiazines are used routinely in the clinics as part of anti-
psychoticmedication.
15Thesecompoundsalsopossesswell-
documented chemosensitizing activities, although their
mode(s) of action is unclear.
16,24 The current study was
designed to map potential phenothiazine-sensitive cellular
processes with relevance to chemosensitivity in lung cancer.
In this study, we demonstrate for the ﬁrst time the ability of
phenothiazines to impede gH2AX resolution, which led to
enhanced killing of human NSCLC cells by bleomycin and
cisplatin. Phenothiazine-co-treated cells underwent pro-
longed initial checkpoint arrest followed by checkpoint
escape, defective mitosis, dramatically increased ROS
production and ﬁnally apoptosis associated with intense
vacuolation and lysosomal expansion (Figure 8). Importantly,
phenothiazine-mediated chemosensitization involves cas-
pases but can also proceed via caspase-independent
mechanisms. In light of the favorable toxicological proﬁle of
phenothiazines, our data support the notion that these
compounds may be useful leads for the development of novel
chemosensitizers against tumors that are insensitive to
chemotherapy-induced caspase-mediated apoptosis.
We have previously identiﬁed TFP as a candidate DNA
repair inhibitor.
17,25 However, we uncovered several notable
differences between TFP and the DNA-PK kinase inhibitor
NU7026. First, TFP was an efﬁcient chemosensitizer of
bleomycin and cisplatin, whereas NU7026 was only able to
confer sensitization to bleomycin. Second, NU7026 but not
TFP conferred radiosensitization in the tested NSCLC cell
lines (data not shown), although we cannot rule out that this
was due to certain cell-intrinsic defects. Third, the initial
induction of gH2AX after bleomycin treatment was slightly
enhanced by TFP but was markedly reduced by NU7026.
These results indicated that TFP is probably not a direct
kinase inhibitor of DNA-PK in intact cells. Nonetheless, TFP
signiﬁcantly retarded the resolution of gH2AX and recovery of
proliferative capacity in U1810 and H23 cells after DNA-
damaging treatment, suggesting that TFP somehow impaired
the efﬁciency of DNA repair
17,26 and/or prevented the
Figure 4 Phenothiazines promotesecondaryarrestandapoptosisin humanlungcancercellsthatrecover fromtheinitialDNA damage-induced checkpoints.U1810cells
wereexposedtoDNA-damagingdrugs(2.5mg/mlbleomycin,20mMcisplatin)aloneorincombinationwithTFP(10mM).(a)TFPmarkedlydelayedtherecoveryofproliferative
capacityofcheckpoint-arrestedU1810cells(left);after72h,bothTFPandTFPZcausedsecondaryarrestinasub-populationofcells(right).CFSElabelingwascarriedout6h
before drug treatment. (b) TFP increased the percentage of bleomycin-treated cells that exhibit signs of abnormal mitosis (e.g., micronucleation, lagging chromosomes and
anaphase bridges) and apoptosis (chromatin condensation and fragmentation, formation of apoptotic bodies). (c) TFP increased the percentage of cisplatin-treated cells that
exhibit signs of abnormal mitosis and apoptosis. Mean and S.D. were compiled from three to four independent experiments performed in duplicates (*Po0.05, TFP
co-treatment versus single-agent bleo/cis treatment)
Phenothiazine-mediated chemosensitization
D Zong et al
6
Cell Death and Diseaseinactivation of signals that maintain cell-cycle checkpoints.
6
Importantly, the ability of TFP to retard gH2AX resolution was
shared by TFPZ, suggesting that it may be a common
property of phenothiazines. The accumulation of unresolved
gH2AX in TFP-co-treated cells likely account for their
decreased clonogenic capacity.
8
A previous report showed that TFP enhanced G2-M arrest
in mouse leukemia cells exposed to bleomycin.
27 We show
that TFP similarly enhanced the arrest of bleomycin-treated
U1810 cells, which mostly accumulated in late G2 and early
mitosis, as judged by their positivity for phosphorylated
(Ser10) histone H3 (data not shown), a marker for chromo-
some condensation.
28 There are two molecularly and
temporally distinct G2-M checkpoints: one of these is fast
and enforces the arrest of cells that were in late S or early G2
at the time they incur DNA damage, while the other is delayed
and arrests cells that were in G1 when they sustained DNA
damage.
29 TFP appeared to prolong cell-cycle arrest
mediated by both of these G2-M checkpoints. In addition,
TFP potentiated cisplatin-induced S-phase arrest in U1810
Figure 5 TFP augments the activation of both the extrinsic and the intrinsic apoptotic pathways after DNA damage. U1810 cells were exposed to DNA-damaging drugs
(2.5mg/ml bleomycin, 20mM cisplatin) alone or in combination with TFP (10mM). For immunoblotting and FLICA assay, samples were collected 48h post DNA-damaging
treatment. (a) TFP augmented caspase-3 activation after bleomycin treatment (left); enhanced caspase-3 activation was detected predominantly in cells containing 4n DNA
content(right).(b)TFPpotentiatedcaspase-3activationaftercisplatintreatment.(c)TFPco-treatmentresultedinincreasedcleavageofPARP.(d)TFPco-treatmentresulted
in increased cleavage of caspase-8. (e) TFP co-treatment resulted in increased cleavage of caspase-9. (f) TFP-co-treated cells contain increased levels of catalytically active
caspase-9. For (a, b and f), mean and S.D. were compiled from three independent experiments performed in duplicates (*Po0.05, TFP co-treatment versus single-agent
bleo/cis treatment). For (c, d and e), the numbers at the top indicate the normalized intensity of the bands. One representative experiment is shown (n¼3)
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Cell Death and DiseaseFigure 6 TFP causes lysosomal dysfunction and vacuolation after DNA damage. U1810 cells were exposed to bleomycin (2.5mg/ml) alone or in combination with TFP
(10mM). (a) TFP co-treatment resulted in enlargement of cells and intense vacuolation after 48h, as judged by light microscopy. (b) TFP-co-treated cells showed time-
dependentincreases in vacuolation, which manifestedas increasedside scatteringduring ﬂow cytometric analysis. (c) TFP caused LMP, as indicatedby decreased retention
of AO, in a subset of bleomycin-treated cells. (d) TFP co-treatment induced dramatic expansion of intracellular acidic compartments, as judged by increased AO retention.
(e) AO retention was positively correlated with vacuolation in U1810; data points cover the entire length of the experiments (0–48h). (f) TFP co-treatment induced the
expansion of lysosomal compartment, as judged by increased staining with LysoTracker Green. (g) Baﬁlomycin A1 reduced AO retention (after 48h) in TFP-co-treated cells.
(h) Baﬁlomycin A1 reduced caspase-3 activation (after 48h) in TFP-co-treated cells. For (g and h), baﬁlomycin A1 (10nM) was added 24h post bleomycin treatment. Mean
andS.D. were compiledfrom threeto ﬁve independent experiments performedin duplicates(*Po0.05, TFPco-treatment versussingle-agent bleotreatment,
#Po0.05, TFP
co-treatment versus TFP co-treatment plus baﬁlomycin A1)
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replication stress triggers gH2AX.
5 It is worth pointing out that
the S-phase checkpoint induced by cisplatin took longer time
to activate compared with the G2-M checkpoint induced by
bleomycin, which was activated almost immediately. This
helps explain why TFP impaired the resolution of bleomycin-
and cisplatin-induced gH2AX with very different kinetics. More
importantly, however, our data clearly showed that the ability
of TFP to delay checkpoint recovery is not dependent on the
type of checkpoint that was engaged.
A comparison of DNA content analysis with CFSE dilution
dynamics revealed that phenothiazine delayed but did not
prevent bleomycin-treated U1810 cells from escaping the
initial G2-M checkpoint, which occurred between 12 and 18h
post-treatment (as opposed to approximately 6h post-treat-
ment in the absence of phenothiazines). However, we
observed a large increase in the number of cells bearing
signs of defective mitoses and apoptosis, suggesting that the
repair of bleomycin-induced DNA DSBs by phenothiazine
co-treated cells was incomplete and/or imprecise. Enhanced
Figure 7 TFP increases endogenous ROS production after DNA-damaging treatment. U1810 cells were exposed to DNA-damaging drugs (2.5mg/ml bleomycin, 20mM
cisplatin) alone or in combination with TFP (10mM). Intracellular ROS was measured by oxidation of the probe CM-H2DCFDA. Short-term cell viability was assayed by PI
exclusion after 48h (bleomycin) or 72h (cisplatin); long-term clonogenic capacity was determined by standard colony formation assay after 9 days. (a) TFP-co-treated cells
showed time-dependent increases in ROS production after exposure to bleomycin (left). The histogram (right) highlights differences in DCFDA-associated ﬂuorescence after
24h: shaded, bleo; unshaded, bleoþTFP. (b) TFP-co-treated cells showed time-dependent increases in ROS production after exposure to cisplatin. (c) N-acetylcysteine
(NAC) partially rescued the short-term viability of cells co-treated with TFP and bleomycin (top) or cisplatin (bottom). NAC (10mM, 48h) was added immediately after
bleomycin treatment and replenished once after 24h. (d) NAC antagonized the suppression of long-term clonogenic capacity by TFP co-treatment. Filled columns,
experimental data; open column, additive combinatorial effect as predicted by the Bliss model. Mean and S.D. were compiled from three to ﬁve independent experiments
performedinduplicates(*Po0.05,TFPco-treatmentversussingle-agentbleo/cistreatment,
yPo0.05,predictedadditivecombinatorialeffectsofTFPco-treatmentplusNAC
versus observed combinatorial effects of TFP co-treatment plus NAC)
Phenothiazine-mediated chemosensitization
D Zong et al
9
Cell Death and Diseasecaspase-3 activation has been reported as a feature of
TFP-mediated chemosensitization in mouse cells,
27 although
how it was achieved was not explored further. In this study we
show for the ﬁrst time that TFP and related phenothiazines
augmented caspase-3 activation speciﬁcally in bleomycin-
treated U1810 cells residing in G2-M, possibly as a conse-
quence of secondary arrest and/or aberrant mitosis.
Moreover, we found that TFP enhanced the cleavage of both
caspase-8andcaspase-9, indicatingthe activation ofboth the
extrinsic and the intrinsic apoptotic pathways. Intriguingly,
silencing of caspase-2 expression by siRNA partially reduced
caspase-3 activation in TFP-co-treated U1810 cells (data not
shown), although we could not detect caspase-2 cleavage by
immunoblotting. In addition, increased mitochondrial depolar-
ization and release of AIF (data not shown) were detected in
TFP-co-treated cells. These data implicated the involvement
of both caspase-dependent and caspase-independent path-
ways in phenothiazine-mediated chemosensitization, which
explains the inability of z-VAD-fmk to rescue the clonogenic
capacity of TFP-co-treated cells (data not shown).
We considered that phenothiazines may alter the perme-
ability of plasma membrane,
30 which could inﬂuence drug
uptake. Incubation of TFP for 2h did not appreciably impact
the ability of cells to exclude PI (data not shown), suggesting
that increased drug inﬂux through enhanced membrane
permeability was unlikely. Phenothiazines are also lysosomo-
tropic compounds with calmodulin antagonistic activities.
31,32
Notably, we found that phenothiazines induced intense
vacuolation and increased retention of AO in bleomycin- or
cisplatin-treated U1810 cells, both of which was reversed by
baﬁlomycin A1. As TFP-co-treated cells also stained more
intensely with LysoTracker Green, the increased retention of
AO by these cells was most likely to due expansion of the
lysosomal compartment. This phenomenon was not repli-
cated by the calmodulin inhibitors calmidazolium or W7 in
bleomycin-treated U1810 cells (data not shown), which
argues against a key role for calmodulin antagonism in
phenothiazine-mediated chemosensitization. Although some
cell types may accumulate autophagic vacuoles before
apoptosis,
12 vacuolation of TFP-co-treated U1810 cells did
not involve lipidation of LC3 characteristic of classic autop-
hagy
33 or increased expression of Bnip3,
34,35 a BH3-only
protein that regulates autophagy capable of activating Bak
and Bax (data not shown). In fact, the increased activation of
Bak and Bax evident in TFP-co-treated cells could not be
attributedtochangesintheexpressionofBim, Bid,Mcl-1,Bcl-
XL or Bcl-2 (data not shown). Interestingly, we observed LMP
and marked oxidative stress in TFP-co-treated U1810 cells
(12h post-treatment) long before conformational activation of
Bak and Bax was detected (40h post-treatment). In this
regard, LMP has been shown to generate ROS and induce
cell death in a Bak/Bax-dependent fashion.
11,23 In turn, Bak/
Bax-mediated mitochondrial permeabilization activates cas-
pases, which further disturbs cellular bioenergetics
36 and
exacerbates oxidative stress, ﬁnally leading to mitochondrial
depolarization, permeability transition and release of AIF.
Phenothiazinesmayweakenlysosomesbyalteringtheﬂuidity
of their lipid membrane,
30 making them more likely to rupture.
Indeed, LMP was observed exclusively in TFP-co-treated
cells. It is possible that ROS initially triggered vacuolation as a
cyto-protective response to compensate for the loss of
lysosomal functions through LMP.
20 However, the combina-
tionofLMP,ROSandmitochondrialdysfunctionmaybelethal
to TFP-co-treated U1810 cells by creating a self-sustaining
loop that leads to persistent oxidative stress and excessive
vacuolation. In support of this notion, baﬁlomycin A1
suppressed the expansion of intracellular acidic compartment
and abolished caspase-3 activation in phenothiazine co-
treated cells. Moreover, the clonogenic capacity of TFP-co-
treated cells could be partially restored by the anti-oxidant
compound NAC, which reduced the ROS load in these cells.
Taken together, these data identify ROS as a potentially
importantdeterminantoflysosomalintegrityandaneffectorof
phenothiazine-mediated chemosensitization. Our results
highlight the need for further studies in which the clinical
utility of phenothiazines as sensitizers of conventional
chemotherapy is assessed especially in tumors refractory to
chemotherapy-induced apoptosis.
Materials and Methods
Cells lines and culture conditions. Human NSCLC cell lines U1810 and
H23 were used in the current study. U1810 was established from a patient tumor at
the University of Uppsala, Sweden;
37 H23 was acquired from commercial sources
(American Type Culture Collection, Manassas, VA, USA). Cells were cultured in
RPMI-1640 medium containing L-glutamine and further supplemented with 10%
heat-inactivated fetal calf serum, 100IE/ml penicillin and 100mg/ml streptomycin.
Drugs and drug co-treatment schemes. Bleomycin (Baxter Medical AB,
Kista, Sweden) was dissolved in sterilized PBS. Cisplatin (Hospira Nordic AB,
Stockholm, Sweden) was obtained in the form of ready-to-use infusion solution.
Triﬂuoperazine dihydrochloride (TFP), ﬂuphenazine dihydrochloride (FPZ),
Figure 8 A working model for phenothiazine-mediated chemosensitization.
PhenothiazinesimpairtheresolutionofgH2AXinhumanlungcancercellsthatwere
exposed to DNA-damaging chemotherapy, causing prolonged checkpoint arrest
followed by checkpoint escape, defective mitosis, secondary arrest and/or cell
death.TFPco-treatmentenhancestheintracellularproductionofROS,LMPandthe
subsequent uncontrolled expansion of acidic (lysosomal) compartments. The mode
of cell death exhibits many molecular features associated with apoptosis, including
chromatin fragmentation. Both caspase-dependent and caspase-independent
mechanisms contribute to phenothiazine-mediated chemosensitization. C, caspase
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Cell Death and Diseasechlorpromazine hydrochloride (CPZ) and triﬂupromazine hydrochloride (TFPZ, all
from Sigma-Aldrich, Stockholm, Sweden) and the ATP-competitive DNA-PK
inhibitor 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026, Calbiochem,
Nottingham, UK) were prepared in DMSO and used at a ﬁnal concentration of
10mM. Drug co-treatment was carried out as follows (Figure 1a): exponentially
growingcellswerepre-treatedwithachemosensitizer(1h),thenexposedtoaDNA-
damaging agent in the presence of the chemosensitizer (1h), followed by post-
incubation in medium containing the chemosensitizer (up to 24h). Further post-
incubation beyond 24h was carried out in medium devoid of chemosensitizer. Cells
that were treated with DNA-damaging agent alone received solvent (0.1% DMSO)
instead of chemosensitizer.
Chemicals. Giemsa stain, acridine orange (AO), 40,6-diamidino-2-phenylindole
(DAPI),carboxyﬂuoresceindiacetateN-succinimidylester(CFSE),N-acetylcysteine
(NAC), calmidazolium chloride (CMZ), N-(6-Aminohexyl)-5-chloro-1-naphthalene-
sulfonamide hydrochloride (W7) and baﬁlomycin A1 were from Sigma-Aldrich.
Benzyloxycarbonyl-Val-Ala-Asp ﬂuoromethylketone (z-VAD-fmk) was from BD
PharMingen (San Jose, CA, USA). Propidium iodide (PI), tetramethylrhodamine
ethyl ester perchlorate (TMRE), 5-(and-6)-chloromethyl-20,70-dichlorodihydro-
ﬂuorescein diacetate acetyl ester (CM-H2DCFDA) and LysoTracker Green DND-
26 were from Invitrogen (Stockholm, Sweden).
Colony formation assays. Homogeneous single-cell suspensions of U1810
and H23 cells were plated in 60mm cell
þ culture dishes (Sarstedt, Landskrona,
Sweden). TFP was given either as pre-treatment without post-incubation or pre-
treatment with 24h post-incubation. After 9–14 days, cells were ﬁxed and stained
with Giemsa and colonies consisting of more than 50 cells were counted under a
light microscope. Relative clonogenic survival was calculated by normalizing
surviving fractions against the plating efﬁciency of untreated cells. The Bliss
additivism model was applied to deﬁne the combinatorial effect of bleomycin and
TFP. The model is expressed by the equation C¼AþB–A*B, where C is the
expected combinatorial effect assuming bleomycin and TFP interact additively,
while A and B are the de facto observed individual effect of bleomycin and TFP,
respectively. A theoretical additive dose-response curve (add) was plotted and
compared with the observed experimental data (obs). If the experimental curve is
below the theoretical curve, the interaction is deemed supra-additive.
Flow cytometric analysis of cellular signaling events. Catalytically
active caspase-9 was detected using the FLICA Caspase 9 detection kit
(Immunochemistry Technologies LLC, Bloomington, MN, USA) as per
manufacturer’s instructions. Intracellular ROS and mitochondrial transmembrane
potential were determined by the oxidation of the ROS indicator CM-H2DCFDA
(10mM, 1h) and retention of the potentiometric dye TMRE (50nM, 30min),
respectively. The intracellular acidic compartment was stained with the acidophilic
dyeAO(5mg/ml,15min).Theseﬂuorescentprobe-basedanalyseswereperformed
in non-ﬁxed cells. Antibody-based analyses were performed on paraformaldehyde-
ﬁxed cells suspended in permeabilization buffer (0.1% Triton X-100 and 1% BSA in
PBS). Phosphorylation of H2AX and activation of caspase-3 were assayed with
Alexa Flour 488-conjugated anti-phospho-H2AX (2F3, BioLegend, San Diego, CA,
USA) and phycoethryrin (PE)-conjugated anti-active caspase-3 (BD PharMingen)
antibodies, respectively. Caspase-3 activation in relation to cellcycle positions was
determined by two-color ﬂow cytometry using DAPI as the DNA-labeling agent.
Active Bak and Bax were probed with conformation-sensitive antibodies as
described previously.
38 At least 10000 events were recorded on Becton–Dickinson
FACSCalibur or LSR II ﬂow cytometers(BD Biosciences, San Jose, CA, USA) Data
analysis was conducted using the built-in Cell Quest software.
Determinationof cell-cycleproﬁle, proliferative capacityandcell
viabilityafterDNAdamage. Cellswereﬁxedin70%ethanolandanalysisof
DNA content by PI staining was performed as described by Darzynkiewicz and
Huang.
39 cell–cycle distribution was assigned using ModFit LT (Verity Software
House, Topsham, ME, USA). Recovery of proliferative capacity after DNA damage-
induced G2-M arrest was assessed by the CFSE labeling method. Brieﬂy, U1810
cells were pulse-labeled with 2.5mM CFSE for 5min at room temperature, washed
free of unincorporated dye and incubated in fresh medium. Drug treatment
commenced 6h after the completion of labeling and progressive dilution of CFSE
ﬂuorescence indicates cell proliferation. Cell viability was estimated by PI (1mg/ml)
exclusion. At least 10000 events were collected. Only non-ﬁxed cells were used for
CFSE and PI exclusion assays.
Analysis of nuclear morphology. Cells were ﬁxed in 4% formaldehyde,
dropped onto slides, mounted with VectaShield containing DAPI (Immunkemi F&D
AB, Ja ¨rfa ¨lla, Sweden) and examined under a Zeiss Axioplan-2 ﬂuorescence
microscope at  40magniﬁcation (Carl Zeiss Inc., Thornwood, NY, USA). Each
samplewasanalyzedbycounting200cellsinrandoml-selectedvisualﬁelds.Nuclei
displaying chromatin condensation and DNA fragmentation were scored as apoptotic.
Actual mitotic defects (e.g., lagging chromosomes and anaphase bridges) as well as
micronucleation in interphase cells (which arises as a consequence of defective mitosis)
were collectively categorized as abnormal mitosis.
Immunoblotting. To obtain total cell lysate, cells were lysed in RIPA buffer
(50mM Tris-HCl, pH 7.4, 150mM NaCl, 1mM EDTA, 0.1% Na-deoxycholate and
1% NP-40) supplemented with protease and phosphatase inhibitor cocktail tablets
(Roche Diagnostics AB, Stockholm, Sweden). Cytosolic fraction was obtained as
described previously.
40 In all, 20–30mg of lysates were resolved by SDS-PAGE
(NuPAGE, Invitrogen). Immunoblotting was performed with primary antibodies
recognizing caspase-8 (1C12), cleaved caspase-9 (Asp330), caspase-9, Bim, Bcl-
XL, Mcl-1, p38 (phospho-Thr183/Tyr185, all from Cell Signaling Technology,
Danvers,MA,USA);Bid,Bnip3(bothfromAbcam,Cambridge,UK);PARP(C2-10),
caspase-2 (both from BD Transduction Laboratories, San Jose, CA, USA);
apoptosis-inducing factor (AIF), Bcl-2 (both from Santa Cruz Biotechnologies, CA,
USA); p21 (Calbiochem); histone H3 (phospho-Ser10, Millipore, Temecula, CA,
USA). Where indicated, antibodies against Ku70, Ku80 (both from Abcam) or
GAPDH (Trevigen, Gaithersburg, MD, USA) were used to control for equal loading.
Horseradish peroxidase-linked secondary antibodies (GE Healthcare, Piscataway,
NJ, USA) were used to visualize bands by enhanced chemiluminescence (Thermo
Fisher Scientiﬁc, Waltham, MA, USA). Alternatively, IR-Dye-linked secondary
antibodies (LI-COR Biosciences, Bad Homburg, Germany) were used to image
bands on the Odyssey platform.
Statisticalanalysis. Unlessotherwisestated,allexperimentswereperformed
in duplicates, and repeated three times. Data points are expressed as the mean
±S.D.Two-tailedunpairedStudent’st-testwasusedtocompareTFPco-treatment
with single-agent DNA-damaging treatment. Asterisks (*) indicate statistical
signiﬁcance when Po0.05.
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